Sequential Bilateral Corneal Transplantation and Graft Survival - 12/10/16

on behalf of the
National Health Service Blood and Transplant Ocular Tissue Advisory Group and Contributing Ophthalmologists (OTAG Audit Study 21)
Abstract |
Purpose |
To investigate graft survival and rejection following sequential bilateral corneal transplantation.
Design |
Retrospective cohort study.
Methods |
The study included patients with Fuchs endothelial dystrophy (FED), pseudophakic bullous keratopathy (PBK), or keratoconus who had undergone a penetrating keratoplasty (PK), endothelial keratoplasty (EK), or deep anterior lamellar keratoplasty (DALK) between 1999 and 2012. The main cohort included patients who had received a first transplant in both eyes for the same indication and a control cohort patients who had undergone a unilateral first corneal transplant. Main outcome measures were graft rejection or failure at 5 years.
Results |
A total of 11 822 patients were included, of whom 9335 had a unilateral and 2487 bilateral corneal transplantation. For patients with FED (P < .005) and KC (P = .03) but not PBK (P = .19), a transplant in the second eye was associated with a 50% reduction in risk of graft failure within 5 years in the first eye (FED: hazard ratio [HR] 0.47, 95% confidence interval [CI]: 0.34–0.64; KC: HR 0.50, 95% CI: 0.24–1.02). For FED this was dependent on the type of transplant (EK: HR 0.30, 95% CI: 0.17–0.52; PK: HR 0.61, 95% CI: 0.42–0.88). We found no association between a transplant in the second eye and a rejection episode in the first eye (KC P = .19, FED P = .39, PBK P = .19).
Conclusion |
For FED and KC, a transplant in the second eye was associated with a reduced risk of graft failure in the first eye, independent of inter-transplant time. For FED this effect was pronounced following an EK in the first eye, where the risk of failure was reduced by 70%.
Le texte complet de cet article est disponible en PDF.Plan
| Bernhard Steger and Elinor Curnow contributed equally to this work. |
|
| Supplemental Material available at AJO.com. |
Vol 170
P. 50-57 - octobre 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
